Venturis Therapeutics, Inc.

This trial tests whether injecting a growth factor called FGF-1 directly into the heart can help people with severe coronary heart disease who have no other treatment options. The study compares low and high doses of FGF-1 against a placebo, using a special catheter to deliver th…

This early-stage trial is testing whether a protein called FGF-1, injected into the leg muscle, is safe and tolerable for people with peripheral arterial disease—a condition where narrowed leg arteries cause pain when walking. The study includes adults aged 50 to 75 with intermit…